Developing a new technology for isolating exosomes from biological samples
Capillary-channeled polymers fibers and films - A platform technology for exosome isolation and analytics
['FUNDING_R01'] · CLEMSON UNIVERSITY · NIH-10872294
This study is exploring a new way to collect tiny particles called exosomes that help us understand diseases better, which could lead to improved tests and treatments for patients like you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CLEMSON UNIVERSITY (nih funded) |
| Locations | 1 site (CLEMSON, UNITED STATES) |
| Trial ID | NIH-10872294 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a novel platform technology using capillary-channeled polymer fibers and films to efficiently isolate exosomes, which are tiny vesicles involved in cell communication and disease processes. By improving the methods for capturing and analyzing exosomes, the research aims to enhance our understanding of disease mechanisms and improve clinical diagnostics. Patients may benefit from advancements in disease detection and potential new therapies that utilize exosomes as drug delivery vehicles.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could be diagnosed or treated through exosome analysis.
Not a fit: Patients who do not have conditions related to exosome involvement may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate disease diagnostics and innovative treatment options for patients.
How similar studies have performed: Previous research has shown promise in using exosomes for diagnostics and therapeutics, indicating that this approach could be a significant advancement in the field.
Where this research is happening
CLEMSON, UNITED STATES
- CLEMSON UNIVERSITY — CLEMSON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MARCUS, RICHARD KENNETH — CLEMSON UNIVERSITY
- Study coordinator: MARCUS, RICHARD KENNETH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.